/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Professor Derick Raal is Professor and Head of the Division of Endocrinology and Metabolism at the University of the Witwatersrand, Johannesburg, South Africa. After obtaining his MBBCh degree cum laude in 1981, he obtained his Master of Medicine his PhD in 2000 and his Doctor of Science in 2022. He is a NRF A-rated scientist, was recognized as a Web of Science highly cited researcher for 2021, and has authored or co-authored over 300 original articles and book chapters.
Professor Raal is particularly interested in lipids and lipid disorders and has been integrally involved in the management of familial dyslipidaemia, particularly heterozygous and homozygous familial hypercholesterolaemia (FH). The major focus of his research remains the clinical, biochemical, genetic and therapeutic management of this condition and he continues to conduct studies with novel therapies such as PCSK9-inhibitors and ANGPTL3-inhibitors in this patient group.
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolaemia: the Trial Assessing long-term Use of PCSK9 inhibition in Subjects with Genetic LDL disorders (TAUSSIG)
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipid lowering therapy in primary cardiovascular prevention
